Opinion Article: Res Rev Drug Deliv |
Personalized Cancer Immunotherapies: New Frontiers in Targeted Drug Delivery |
Jordan Daves* |
Perspective Article: Res Rev Drug Deliv |
Drug Regulation and Approval: Impact of Accelerated Processes in the COVID Era |
Duncan Elledge* |
Commentary: Res Rev Drug Deliv |
The Potential of Cell-Based Therapies in Drug Development |
Ursala Fischer* |
Short Communication: Res Rev Drug Deliv |
Metabolism of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) and Their Side Effects |
Kattab Omar |
Commentary: Res Rev Drug Deliv |
Nanoparticles in Drug Delivery for Cancer Immunotherapy |
Patrick Leonard |